James B. Breitmeyer, EVP, CMO at CADENCE PHARMACEUTICALS INC (CADX), sold 39,000 shares at $7.39 ($288K) on 2011-02-03, disclosed to the SEC on 2011-02-04.
Scheduled sale ($288k) by EVP, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | SELL | 2019-12-18 | $250K | — | Filing → |
| ZGNX | SELL | 2019-11-27 | $250K | — | Filing → |
| CADX | SELL | 2011-11-04 | $71K | — | Filing → |